World Health Organization Semaglutide & NAION safety alert (June 2025): The official global notice confirming NAION as a recognised very-rare risk
Clostridium butyricum (1 Billion CFU) Clostridium butyricum is a spore-forming probiotic strain with documented use in clinical and commercial settings, particularly in Asian and European markets
Clinical Trial Results Clinical trials have highlighted its efficacy, with participants experiencing significant weight reductions: Mounjaro Study Results: The SURMOUNT-1 trial (NEJM 2022) showed individuals with obesity losing up to 2022.5% of their body weight, surpassing many other weight-loss drugs in the market
Its a reapplication of a well-understood treatment, now being used with a better understanding of how the body is regulatedespecially in people with metabolic resistance (thats a polite way of saying no matter how hard they try, they cant seem to lose weight)
Transparent research-grade quality
Better Metabolic Flexibility and Mitochondrial Health Metabolic flexibilitythe ability to switch between burning carbohydrates and fatsis impaired in obesity and insulin resistance